Your browser doesn't support javascript.
loading
Prostate cancer androgen receptor splice variant 7 biomarker study - a multicentre randomised feasibility trial of biomarker-guided personalised treatment in patients with advanced prostate cancer (the VARIANT trial) study protocol.
Clark, Emma; Morton, Miranda; Sharma, Shriya; Fisher, Holly; Howel, Denise; Walker, Jenn; Wood, Ruth; Hancock, Helen; Maier, Rebecca; Marshall, John; Bahl, Amit; Crabb, Simon; Jain, Suneil; Pedley, Ian; Jones, Rob; Staffurth, John; Heer, Rakesh.
Afiliación
  • Clark E; Translational and Clinical Research Institute, NU Cancer, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK emma.clark@ncl.ac.uk.
  • Morton M; Newcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
  • Sharma S; Newcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
  • Fisher H; Population Health Sciences, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
  • Howel D; Population Health Sciences, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
  • Walker J; Newcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
  • Wood R; Newcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
  • Hancock H; Newcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
  • Maier R; Newcastle Clinical Trials Unit, Newcastle University, Newcastle upon Tyne, Tyne and Wear, UK.
  • Marshall J; Trial Managment Group, VARIANT Trial, Newcastle-Upon-Tyne, UK.
  • Bahl A; University Hospitals Bristol NHS Foundation Trust, Bristol, Bristol, UK.
  • Crabb S; University of Southampton, Southampton, UK.
  • Jain S; Queen's University Belfast, Belfast, Belfast, UK.
  • Pedley I; Newcastle Upon Tyne Hospitals NHS Foundation Trust, Newcastle Upon Tyne, Newcastle upon Tyne, UK.
  • Jones R; University of Glasgow, Glasgow, Glasgow, UK.
  • Staffurth J; Research, Velindre Cancer Centre, Cardiff, Cardiff, UK.
  • Heer R; Division of Cancer and Genetics, Cardiff University School of Medicine, Cardiff, Cardiff, UK.
BMJ Open ; 9(12): e034708, 2019 12 18.
Article en En | MEDLINE | ID: mdl-31857319
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Receptores Androgénicos / Biomarcadores de Tumor / Células Neoplásicas Circulantes Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Aspecto: Ethics Límite: Humans / Male Idioma: En Revista: BMJ Open Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias de la Próstata / Receptores Androgénicos / Biomarcadores de Tumor / Células Neoplásicas Circulantes Tipo de estudio: Clinical_trials / Guideline / Prognostic_studies Aspecto: Ethics Límite: Humans / Male Idioma: En Revista: BMJ Open Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido